Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
Phase 1
Recruiting
- Conditions
- Primary AldosteronismPrimary Aldosteronism Due to Aldosterone Producing Adenoma
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT06773663
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
A Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis
Not yet recruiting
- Conditions
- HPV InfectionIntravenous Leiomyomatosis
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06773819
AI in Predicting Polyp Pathology and Endoscopic Classification
Recruiting
- Conditions
- Colorectal Polyps
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06773832
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors
Not Applicable
Recruiting
- Conditions
- Endometrial Cancer
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06774209
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial
Phase 2
Not yet recruiting
- Conditions
- Recurrent/Metastatic Endometrial Cancer
- Interventions
- Drug: Adebelimab Combined with ApatinibDrug: Adebelimab
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT06771154
- Locations
- 🇨🇳
Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences, Beijing, China, Beijing, China
Effects of Intraoperative Glycemic Management Strategies Assisted with RT-CGM on TIR and Postoperative Recovery
Not Applicable
Not yet recruiting
- Conditions
- Continuous Glucose Monitoring
- First Posted Date
- 2025-01-01
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 246
- Registration Number
- NCT06755788
Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer
Phase 2
Not yet recruiting
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Drug: Aumolertinib
- First Posted Date
- 2024-12-30
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 316
- Registration Number
- NCT06752408
- Locations
- 🇨🇳
Peking Union Medical College Hospital,, Beijing, Beijing, China
Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy
Early Phase 1
Recruiting
- Conditions
- Inherited Retinal Diseases
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT06749639
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method
Recruiting
- Conditions
- Primary Aldosteronism
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT06750172
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma
Not yet recruiting
- Conditions
- Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06750159
© Copyright 2025. All Rights Reserved by MedPath